| OMIC signatures to understand cancer immunosurveillance and immunoediting: Melanoma and immune cells interplay in immunotherapy RA León-Letelier, LC Bonifaz, EM Fuentes-Pananá Journal of leukocyte biology 105 (5), 915-933, 2019 | 20 | 2019 |
| Mining the immunopeptidome for antigenic peptides in cancer RA León-Letelier, H Katayama, S Hanash Cancers 14 (20), 4968, 2022 | 14 | 2022 |
| Induction of Progenitor Exhausted Tissue-Resident Memory CD8+ T Cells Upon Salmonella Typhi Porins Adjuvant Immunization Correlates With Melanoma … RA León-Letelier, DI Castro-Medina, O Badillo-Godinez, A Tepale-Segura, ... Frontiers in Immunology 11, 583382, 2020 | 13 | 2020 |
| Induction of therapeutic protection in an HPV16-associated mouse tumor model through targeting the human papillomavirus-16 E5 protein to dendritic cells O Badillo-Godinez, A Pedroza-Saavedra, V Valverde-Garduño, ... Frontiers in Immunology 12, 593161, 2021 | 9 | 2021 |
| Kynureninase upregulation is a prominent feature of NFR2-activated cancers and is associated with tumor immunosuppression and poor prognosis RA León-Letelier, AH Abdel Sater, Y Chen, S Park, R Wu, E Irajizad, ... Cancers 15 (3), 834, 2023 | 6 | 2023 |
| c-MYC-driven polyamine metabolism in ovarian cancer: from pathogenesis to early detection and therapy Y Chen, RA León-Letelier, AH Abdel Sater, J Vykoukal, JB Dennison, ... Cancers 15 (3), 623, 2023 | 6 | 2023 |
| The kynurenine pathway presents multi-faceted metabolic vulnerabilities in cancer RA León-Letelier, R Dou, J Vykoukal, AHA Sater, E Ostrin, S Hanash, ... Frontiers in Oncology 13, 1256769, 2023 | 5 | 2023 |
| Contributions of the Microbiome-Derived Metabolome for Risk Assessment and Prognostication of Pancreatic Cancer RA León-Letelier, R Dou, J Vykoukal, MT Yip-Schneider, A Maitra, ... Clinical chemistry 70 (1), 102-115, 2024 | 3 | 2024 |
| Integrated spatial transcriptomics and lipidomics of precursor lesions of pancreatic cancer identifies enrichment of long chain sulfatide biosynthesis as an early metabolic … M Sans, Y Chen, FI Thege, R Dou, J Min, M Yip-Schneider, J Zhang, ... bioRxiv, 2023.08. 14.553002, 2023 | 1 | 2023 |
| A citrullinated-ENO1 peptide vaccine delayed tumor growth and markedly improved overall survival in a mouse model of triple-negative breast cancer RAL Letelier, H Katayama, Y Chen, Y Cai, F Hsiao, B Arun, S Hanash Cancer Research 84 (6_Supplement), 4098-4098, 2024 | | 2024 |
| Integrated spatial transcriptomics and lipidomics analyses of intraductal papillary mucinous neoplasm identifies enrichment of long chain sulfatide as an early metabolic alteration Y Chen, M Sans, F Thege, R Dou, J Min, M Yip-Schneider, J Zhang, R Wu, ... Cancer Research 84 (6_Supplement), 446-446, 2024 | | 2024 |
| Vesicle-mediated mitochondrial clearance underlies an actionable metabolic vulnerability in triple-negative breast cancer J Vykoukal, Y Chen, MJ Hong, M Zuo, H Krishna, H Katayama, E Irajizad, ... bioRxiv, 2024.04. 04.587899, 2024 | | 2024 |
| Relationship between EGFR inhibition in lung adenocarcinoma, cell surface expression of the placental antigen ALPP, and efficacy of ALPP-ADC therapy. H Katayama, Y Chen, M Hong, H Xu, J Vykouka, S Park, Y Cai, ... Journal of Clinical Oncology 41 (16_suppl), e15018-e15018, 2023 | | 2023 |
| Kynureninase Upregulation Is a Feature of NRF2-upregulated Lung Cancers and Is Associated With Tumor Immunosuppression and Poorer Prognosis E Ostrin, R Leon-Letelier, AA Sater, E Irajizad, Q Peng, J Mayo, J Casabar, ... D31. IMAGING, BIOMARKERS, AND MACHINE LEARNING IN LUNG CANCER, A6529-A6529, 2023 | | 2023 |
| KYNU upregulation is a prominent feature of NRF2-activated cancers and is associated with tumor immunosuppression and poor prognosis RAL Letelier, AHA Sater, Y Chen, R Wu, JB Dennison, S Park, E Irajizad, ... Cancer Research 83 (7_Supplement), 6031-6031, 2023 | | 2023 |
| A liquid biopsy approach to gastric cancer reveals a signature reflective of epithelial to mesenchymal transition AHA Sater, Y Chen, JF Fahrmann, E Irajizad, Y Cai, F Hsiao, JV Vykoukal, ... Cancer Research 83 (7_Supplement), 2017-2017, 2023 | | 2023 |
| EGFR inhibition in lung adenocarcinoma upregulates cell surface expression of the placental antigen ALPP and enhances efficacy of ALPP-ADC therapy Y Chen, MJ Hong, H Xu, J Vykoukal, S Park, Y Cai, RA León-Letelier, ... bioRxiv, 2023.03. 27.534173, 2023 | | 2023 |
| Mining the Immunopeptidome for Antigenic Peptides in Cancer. Cancers 2022, 14, 4968 RA León-Letelier, H Katayama, S Hanash s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2022 | | 2022 |
Hiroyuki KatayamaUniv. of Texas, MD Anderson Cancer Center在 mdanderson.org 的电子邮件经过验证
